In a report released today, Michael Petusky from Barrington maintained a Buy rating on DENTSPLY SIRONA (XRAY – Research Report), with a price target of $51.00. The company's shares closed last Thursday at $35.91, close to its 52-week low of $33.78. According to TipRanks.com, Petusky is a 4-star analyst with an average return of 8.1% and a 50.9% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, ATI Physical Therapy, and US Physical Therapy. Currently, the analyst consensus on DENTSPLY SIRONA is a Moderate Buy with an average price target of $43.10.
https://www.tipranks.com/news/blurbs/barrington-thinks-dentsply-sironas-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Sep 2022 bis Okt 2022 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Okt 2021 bis Okt 2022 Click Here for more DENTSPLY SIRONA Charts.